Article Details
Retrieved on: 2024-09-07 11:06:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Infliximab and adalimumab, both monoclonal antibodies targeting tumor necrosis factor (TNF)-α, were the earliest biologic therapies indicated for ...
Article found on: www.centerforbiosimilars.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here